PROVIDER PROFILE · NPI 1982667754

Mark DiehlDO

RheumatologyGettysburg, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

952

Unique beneficiaries

—

Total services

11,174

Distinct HCPCS

Medicare payment

$271K

Peer benchmark

Total Medicare services vs. 267 Rheumatology providers in PA — above median (cohort median 4,116).

PRESCRIBING · PART D · 2024

Total Rx claims

4,374

Beneficiaries

—

Total drug cost

$5.0M

Distinct drugs

Brand share

32.4%

Top prescribed drugs

Prednisone991 claims

Hydroxychloroquine Sulfate644 claims

Methotrexate Sodium642 claims

Sulfasalazine379 claims

Leflunomide279 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$18K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$17K

Food and Beverage$903

Travel and Lodging$440

Education$70

REFERRAL NETWORK

Where Mark Diehl's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE GETTYSBURG HOSPITAL	241	1,048
RAHMAN, RUKHSANA	35	76
YORK HOSPITAL	35	67
Amy-Beth Garazo Diagnostic Radiology · Gettysburg, PA	31	59
ARMAH, KWASI	29	44
SPAGNOLI, MARIE	22	38
NPI 1316996598	14	32
SIVENDRAN, THARMALINGAM	11	18

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history